Nuclear Medicine Market to reach USD 38.8 billion by 2032 and grow at a CAGR of 15%
Rising cancer and cardiovascular diseases, an increase in preference toward non-invasive diagnostic methods, and the development of novel radiopharmaceuticals are accelerating the nuclear medicine market growth. The World Nuclear Association Analysis 2024 estimates around 50 million nuclear medicine procedures a year globally and the demand for radioisotopes increases by about 5% a year.